Cite
Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer
MLA
Thomas Held, et al. “Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer.” Cancers, vol. 11, no. 3, Mar. 2019, p. 383. EBSCOhost, https://doi.org/10.3390/cancers11030383.
APA
Thomas Held, Sati Akbaba, Kristin Lang, Semi Harrabi, Denise Bernhardt, Christian Freudlsperger, Steffen Kargus, Peter Plinkert, Stefan Rieken, Klaus Herfarth, Jürgen Debus, & Sebastian Adeberg. (2019). Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer. Cancers, 11(3), 383. https://doi.org/10.3390/cancers11030383
Chicago
Thomas Held, Sati Akbaba, Kristin Lang, Semi Harrabi, Denise Bernhardt, Christian Freudlsperger, Steffen Kargus, et al. 2019. “Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer.” Cancers 11 (3): 383. doi:10.3390/cancers11030383.